The remarkable resources of the Danish health registries are spotlighted in this issue with two papers describing their utilization in the study of twins. 1, 2 The Danish MS registry, begun in the 1950s by the late K Hyllested, represents one of the most valuable resources in MS research. It has provided methodologically sound and often definitive studies on a variety of epidemiologic perspectives and has been reliably quarried by Nils Koch-Henriksen et al . over many years. The studies of twins reported in this issue result from the convenient marriage of the twin and MS registries. Each investigation is indebted in no small measure to laudable Danish foresight dating back more than two generations. 3 The Danish population-based twin data show results which demonstrate monozygotic and dizygotic concordances nearly identical to those seen in consecutive serial studies in independent cohorts reported from Canada. 4 Á 6 Although the Canadian data represent three serial consecutive studies, each giving the same result, each also used the same approach. In contrast, the Danish studies took a methodologically different route, ascertaining MS cases within the twin and MS registries, while the Canadian studies ascertained twins among large MS clinic populations. The Danish results make an important contribution to other large population-based datasets. Ascertainment has been carefully assessed in this study which, similar to the recent Canadian update, is largely free of the usual confounders. Since two different population-based approaches have yielded the same result, the findings provide more than the usual assurance that the results are valid. The findings are further complemented both by smaller registry studies, 7 and larger ones with yet other routes of ascertainment. 8, 9 Although proband-wise concordances should be used, there is, to be sure, some blurring of complete and incomplete ascertainment in large national studies. Nevertheless, all show reassuringly similar concordances and none are outside the confidence intervals of the Canadian studies. As such, it can be reliably concluded that the MZ concordances in northern countries are consistent at approximately 25 Á/30% with rates of 3 Á/5% for DZ pairs.
The nature of the Danish study has not yet allowed more direct exploration of concordance by history and examination of pairs said to be discordant by registry listing. It is hoped that this may some day be possible, particularly in the dizygotic pairs, where a modest increase has been found compared to sibs but this did not reach statistical significance. 6 Here the confidence intervals for fraternal pairs' concordance remain wide enough that a conceptually important difference compared to sibs has not been excluded. This could conveniently come from the twin families themselves, a reference point which would expand the scope of the Danish data.
Results in northern countries serve to frame recent studies in southern Europe. Now that the Italian national study (Ristori et al ., unpublished data) coheres with the French results, 7 both showing similar and considerably lower concordance for MZ pairs than in the north, there is the strong implication that these rates are related to the background prevalence. How should this be interpreted given that pairs of identical twins seem to vary their concordance based on background risk? The initial emphasis of the French study suggested that somehow it was methodologically at odds with the Canadian data even though the 95% CIs overlapped. It now seems the concordances may be genuinely different. The overall genetic load, be it simply allelic or determined by independent loci singly or multiply interactive, is ordinarily the prime suspect when there is true regional variance in concordance. There is no reason to doubt this a priori . However, this has been recently explored by examining HLA-DRB1 allele frequencies in concordant versus discordant pairs. Perhaps unexpectedly, these were not found to differ among Canadian pairs. 6 This could be seen as supporting the possibility that differing MZ concordance rates are determined not by genes alone, but by variation on the environmental side, hinting at specific gene Á/ environment interactions. However, this analysis could have been underpowered to detect a difference and does not entirely exclude genetic load. Furthermore, the MHC was the only locus examined. There is nothing mutually exclusive about the two interpretations and inconveniently, it may well be that genetic and environmental gradients coexist. Reliable black and white results in MS continue to be scarce even where this is meant literally. Although these considerations remain somewhat unresolved, they are at the heart of what are the most fundamental questions about disease pathogenesis.
There is a widely held view in disorders of unknown etiology and even in complex traits that high MZ versus DZ concordance rates reflect the strength of genetic factors relative to environmental factors, a concept inherent in calculations of 'heritability'. This has somewhat yielded to a second perspective with the recognition that this difference could be primarily determined by the number of susceptibility loci, their allelic relationship to risk, and their pattern of inheritance. Simply put, more loci mean a greater MZ DZ difference and this is most strikingly illustrated by autism, where the MZ/DZ ratio is very high. 10 This model does make testable predictions about more distal inheritance which have not yet been entirely sustained and the site of action of responsible genes remains obscure. Nevertheless it is useful to recall that this was the line of reasoning which led Little to estimate the number of histocompatibility loci to be approximately 20, a few short years after the rediscovery of Mendel and a generation before Snell's conceptions about H-2, the mouse analogue of the major histocompatibility complex in the human. 11 The crucial role of environment in disease pathogenesis is implicit in the appropriately influential results from the US Veterans study (Kurtzer) and from Australia (McLoed). However, these have not shed light on how genes and environment relate to each other, directly or indirectly. The data are not at all inconsistent with independent additive mechanisms and do not require the implications of direct interaction. However, the twin findings from Denmark, Canada and other northern countries, and now from Italy and France can also be viewed as consistent with a somewhat different concept that is not exclusive of the previous notions. This third interpretation is that the degree of concordance is varied by environmental input into what is a gene Á/environment interaction. Take the case of malignant hyperthermia, unknown in the 19th century, but emerging in the 20th century when adequate environmental (anaesthetic) stimuli appeared. Calculations of heritability and their meaning should be viewed in the context of this very simple example of a gene Á/ environment interaction. Low 'heritability', as it is uninformatively calculated, is not inconsistent with an absolute requirement for a permissive allele that would then determine disease frequency, geography and familiality as the exposure became ubiquitous. There are potential lessons here but in the case of MS, environmental effect(s) which result(s) in a threshold for disease penetrance being exceeded may be more stochastic than they are discrete events.
There are many additional questions to be asked of twin studies in MS. For example, none have been able to determine chorionicity. It would be valuable to know if concordance among MZ pairs is influenced by this anatomic feature, 12 only sporadically available in obstetric records. If a difference were found, there would be implications related to a shared circulation. Similarly, there has been no systematic study of right Á/left symmetry and concordance, but there are now enough twins identified to test this as an improbable but possible risk factor. Mirror-image twins would provide a particularly efficient way of doing it unless a different mechanism account for twin and non-twin polarity. Although there have been studies examining expression profiles or X-inactivation in discordant MZ pairs, no clear consensus pattern has emerged and the number of observations is small. The unaffected discordant MZ twin continues to represent a relatively unutilized control for a variety of features in MS as they might characterise the premorbid state, ranging from cognitive dysfunction to epigenetics.
The second paper from Hansen et al . shows that the rate of MS in DZ pairs is actually lower than expected from overall population prevalence. This perhaps should be considered a tentative conclusion, since the question was apparently not part of an a priori hypothesis. To support their point for under representation of MS in DZ twins, they suggest similar findings were present in the Canadian sample. The recalculation to support this was based on textbook twin rates when rates for the Canadian population itself over time are available and seem a better basis for comparison. The variation in such rates over time within the same population may require a more detailed analysis than has been carried out to date. MZ twin occurrence in the Danish sample was in the opposite direction to that for DZs, i.e., over represented by a similar magnitude.
It is possible that it is the rate of MS in MZ twins which is increased in the Danish data and here the awareness of biologic factors common to such twins more readily yields explanatory hypotheses. Over-ascertainment of MZ, common to other twin studies, is not expected in a registry study. DZ rates vary widely and there is much evidence to indicate that the rate of DZ twinning is itself genetically determined so there is rationale for using populationspecific rates. Nevertheless, an interesting question is raised, one which may also apply to the Italian population and will require more analysis. There are now several hints suggesting that events early in life and development influence MS risk. This could be another, but a coherent explanation for the MZ DZ difference in risk (we are not refering to concordance here) seen in the Danish study is not immediately obvious. However, no likely ascertainment artefact other than a vagary of chance springs to mind. Pooling MS incidence in the two twin types in the Danish data gives results approaching that predicted by chance for twins in general.
These studies represent valuable contributions but also highlight the continued value of the longitudinal view taken by the original developers of these powerful national registries. I am confident they will continue to provide insights into MS, and that the enormous efforts made into their assembly have been well justified and will continue to be rewarded. From the standpoint of other complex traits, informative twin studies in MS are not the only clinical genetic epidemiologic realm in which MS research has been envied. The realisation of national databases and registries in MS which have few if any equals among other much more common disorders, owes much to the original Danish example and there is every reason to believe that additional debt will be incurred.
